| __timestamp | Evotec SE | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 79696000 |
| Thursday, January 1, 2015 | 18343000 | 93236000 |
| Friday, January 1, 2016 | 18108000 | 150842000 |
| Sunday, January 1, 2017 | 17614000 | 150643000 |
| Monday, January 1, 2018 | 35619000 | 150252000 |
| Tuesday, January 1, 2019 | 58432000 | 140804000 |
| Wednesday, January 1, 2020 | 63945000 | 34236000 |
| Friday, January 1, 2021 | 72200000 | 35672000 |
| Saturday, January 1, 2022 | 76642000 | 66607000 |
| Sunday, January 1, 2023 | 57519000 | 76363000 |
| Monday, January 1, 2024 | 79048000 |
Unleashing the power of data
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Halozyme Therapeutics, Inc. and Evotec SE have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Halozyme's R&D expenses peaked in 2016, reaching nearly double that of Evotec's highest expenditure in 2022. However, Halozyme's spending saw a significant decline post-2019, dropping by over 75% by 2021. In contrast, Evotec steadily increased its R&D budget, achieving a 500% growth from 2014 to 2022. This divergence highlights Halozyme's shift towards operational efficiency, while Evotec continues to prioritize innovation. As the biotech industry evolves, these strategic choices will shape their competitive edge and market positioning.
Eli Lilly and Company or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
Research and Development Investment: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Madrigal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Halozyme Therapeutics, Inc. and Corcept Therapeutics Incorporated
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and MannKind Corporation
Comparing Innovation Spending: Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Halozyme Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?